Semnur Pharmaceuticals
Latest round
- Series A
Last raised
- Jan 2015
Total raised
- $16M
Investors
- 3
About Semnur Pharmaceuticals
Semnur Pharmaceuticals, Inc.Founded in 2013 in Los Altos, US, Semnur Pharmaceuticals, Inc. focuses on creating non-opioid solutions for chronic pain. The company was acquired by Scintilla Pharmaceuticals, Inc. in August 2016 for an initial USD 60 mn, with additional performance-based payments.Semnur Pharmaceuticals, Inc. specializes in the development and commercialization of novel non-opioid therapeutics aimed at addressing chronic pain management, focusing on conditions such as lumbar radicular pain (sciatica). Their flagship product, SP-102 (SEMDEXA™), is a preservative-free injectable corticosteroid gel formulation designed for moderate to severe chronic radicular pain, providing pain relief through targeted transforaminal injections.S.R.S.Operating through a B2B model, Semnur Pharmaceuticals generates revenue by collaborating with healthcare practitioners and pain management specialists, selling SP-102 (SEMDEXA™) to healthcare facilities like hospitals and pain management clinics. This proprietary product is used in epidural steroid injection procedures for sciatica patients. The company aims to broaden its market reach, particularly in new geographic regions, though specific plans and timelines have not been detailed.
Who invested in Semnur Pharmaceuticals
3 investors across 2 rounds
See all investors in Semnur Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Semnur Pharmaceuticals
Who invested in Semnur Pharmaceuticals?
Semnur Pharmaceuticals has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Semnur Pharmaceuticals raised?
Semnur Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Semnur Pharmaceuticals last raise money?
Semnur Pharmaceuticals's most recent round on record is a Series A, in Jan 2015.
What does Semnur Pharmaceuticals do?
Semnur Pharmaceuticals is a pharmaceuticals company.
Where is Semnur Pharmaceuticals headquartered?
Semnur Pharmaceuticals is headquartered in Los Altos, US.
Which VCs invest in companies like Semnur Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Semnur Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Semnur Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.